Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
The Union health ministry will set up a vaccine manufacturing unit with World Health Organisation's licence and a medical park at Chengalpattu, 30 km from Chennai, at an investment of Rs 300 crore to Rs 500 crore. Speaking to reporters in Chennai on Saturday, Union Health Minister Anbumani Ramadoss said …
The three public sector vaccine manufacturing units in the country could be allowed to resume production if their restructuring was possible, Union Health Minister Anbumani Ramadoss said on Saturday. Dr. Anbumani told mediapersons that a committee appointed by the Union Ministry of Health would visit the three units to investigate …
Fighting malarial drug resistance WILL the world lose another miracle cure? Fifty years ago chloroquine seemed to be an unbeatable malaria remedy. But as the popularity spread of this synthetic form of quinine (a tree extract), the biological backlash began in the form of drug resistance. Today it is not …
A large number of students of primary schools in the district are suffering from anaemia and worm infection. To tackle the problem, a campaign to "de-worm" primary schoolchildren of the state has been started with a target of giving oral pills to 13,63,466 students. The children will be given a …
Reflecting on how far we have come scientifically since isolating HIV in 1983, Anthony S. Fauci urges a renewed commitment to the far greater challenges ahead, especially that of vaccine development.
Six foreign firms acquired in April AFTERa slow beginning, things are hotting up for the pharma sector on deal street. Last month, Indian drug firms acquired six overseas companies, including the $255 million acquisition of US-based Draxis Health Inc by Jubilant Organosys. Besides, the month also saw one of the …
Ranbaxy Laboratories, Dr Reddy's Laboratories, Nicholas Piramal and other pharmaceutical companies are betting on inlicensing or strategic marketing tie-ups to help grow local sales after India banned copying of patented drugs. According to analysts, Indian drug makers are forging alliances with overseas companies such as CD Pharma, Gnosis SpA, Crawford …
According to an Assocham study, the lethal fake drugs market is growing at 25% annually. Lending urgency to the study is a recent research article in the Lancet journal, which says that in developing countries like India, 10-30% of medicines is feared to be counterfeit. The health ministry's estimates are …
Who is interested in controlling spiraling drug prices or, for that matter, the skyrocketing healthcare costs? Both are interconnected although healthcare means a total package, of which drugs and pharmaceuticals form an important integral part. For medical treatment, which does not require hospitalization, the cost of drugs often takes a …
Ranbaxy has signed a collaboration agreement with US-based Merck for drug discovery and clinical development in anti-infective drugs. Ranbaxy and Merck will work together to develop clinically validated anti-bacterial and anti-fungal drug candidates. Ranbaxy will carry out drug discovery and clinical development through Phase IIa clinical trials, with Merck conducting …
Last week, the US Food and Drug Administration (FDA) told a Congressional hearing that it believes a contaminant found in batches of heparin, which have killed at least 81 patients, might have been deliberately added. The source of the contaminant
Objections raised by the health ministry over proposals made in the National Pharmaceutical Policy 2006 resulted in the meeting of Group of Ministers (GoM), formed to deliberate the draft, ended on an inconclusive note on Wednesday. "Whatever proposals (in the policy) we have received, health ministry has a different opinion …
A range of antimalarial drugs were procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries, situated in the part of that continent and the world that is most highly endemic for malaria. Semiquantitative thin-layer chromatography (TLC) and dissolution testing were used to …
After consecutive litigation losses against Pfizer in its bid to grab a market share of the world's largest selling drug, Lipitor, Ranbaxy can now breathe easy. Last week, the Indian company got a shot in the arm, with the US Patent and Trademark Office (USPTO) issuing a a preliminary rejection …
The Union Health Ministry will procure vaccines from private manufacturers at less than half the market price for a two-year period. The procurement will be at no extra cost to the government, Health Minister Anbumani Ramadoss told The Hindu. Written agreements were drawn up with private manufacturers to provide vaccines …
In Tanzania, millions of people seek treatment for malaria through the private sector. But most cannot afford effective medicines. Now a pilot study is testing whether a drug subsidy scheme could help these patients, with some positive preliminary results.
It looks a bit like the coolers used to keep drinks fresh on a sunny day but the chill box being tested in sweltering Mozambique serves a higher purpose -- saving lives from malaria. The new cool box is intended to keep malaria medicines at 25 degrees Celsius (77 degrees …
